CD40/CD40L signaling and its implication in health and disease

BioFactors

Volumn 35, Issue 6, 2009, Pages 474-483

  Chatzigeorgiou, Antonios ^a   Lyberi, Maria ^a   Chatzilymperis, Gregorios ^a   Nezos, Adrianos ^a   Kamper, Elli ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autoimmunity; CD40; Inflammation; Isoform

Indexed keywords

CD40 LIGAND; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE;

AUTOIMMUNE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 73349109464     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.62     Document Type: Review

References (135)

1. Schonbeck, U. and Libby, P. (2001) The CD40/CD154 receptor/ligand dyad. Cell Mol. Life Sci. 58, 4-43.
2. Ferrari, S., Giliani, S., Insalaco, A., Al-Ghonaium, A., Soresina, A. R., Loubser, M., Avanzini, M. A., Marconi, M., Badolato, R., Ugazio, A. G., Levy, Y., Catalan, N., Durandy, A., Tbakhi, A., Notarangelo, L. D., and Plebani, A. (2001) Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA 98, 12614-12619.
3. Braesch-Andersen, S., Paulie, S., Koho, H., Nika, H., Aspenstrom, P., and Perlmann, P. (1989) Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40. J. Immunol. 142, 562-567.
4. Naismith, J. H. and Sprang, S. R. (1998) Modularity in the TNF-receptor family. Trends Biochem. Sci. 23, 74-79.
5. Singh, J., Garber, E., Van Vlijmen, H., Karpusas, M., Hsu, Y. M., Zheng, Z., Naismith, J. H., and Thomas, D. (1998) The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci. 7, 1124-1135.
6. van Kooten, C. and Banchereau, J. (2000) CD40-CD40 ligand. J. Leukoc. Biol. 67, 2-17.
7. Henn, V., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G., and Kroczek, R. A. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591-594.
8. Mach, F., Schonbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J. Y., Pober, J. S., and Libby, P. (1997) Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94, 1931-1936.
9. Chen, Y., Chen, J., Xiong, Y., Da, Q., Xu, Y., Jiang, X., and Tang, H. (2006) Internalization of CD40 regulates its signal transduction in vascular endothelial cells. Biochem. Biophys. Res. Commun. 345, 106-117.
10. Yellin, M. J., Winikoff, S., Fortune, S. M., Baum, D., Crow, M. K., Lederman, S., and Chess, L. (1995) Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukoc. Biol. 58, 209-216.
11. Kenyon, N. S., Chatzipetrou, M., Masetti, M., Ranuncoli, A., Oliveira, M., Wagner, J. L., Kirk, A. D., Harlan, D. M., Burkly, L. C., and Ricordi, C. (1999) Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. Natl. Acad. Sci. USA 96, 8132-8137. (Pubitemid 29328420)
12. Wagner, D. H., Jr., Vaitaitis, G., Sanderson, R., Poulin, M., Dobbs, C., and Haskins, K. (2002) Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc. Natl. Acad. Sci. USA 99, 3782-3787.
13. Waid, D. M., Vaitaitis, G. M., and Wagner, D. H., Jr. (2004) Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus. Eur. J. Immunol. 34, 1488-1497.
14. Waid, D. M., Wagner, R. J., Putnam, A., Vaitaitis, G. M., Pennock, N. D., Calverley, D. C., Gottlieb, P., and Wagner, D. H., Jr. (2007) A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes. Clin. Immunol. 124, 138-148.
15. Munroe, M. E. and Bishop, G. A. (2007) A costimulatory function for T cell CD40. J. Immunol. 178, 671-682.
16. Reyes-Moreno, C., Girouard, J., Lapointe, R., Darveau, A., and Mourad, W. (2004) CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J. Biol. Chem. 279, 7799-7806.
17. Werneburg, B. G., Zoog, S. J., Dang, T. T., Kehry, M. R., and Crute, J. J. (2001) Molecular characterization of CD40 signaling intermediates. J. Biol. Chem. 276, 43334-43342.
18. Reyes-Moreno, C., Sharif-Askari, E., Girouard, J., Leveille, C., Jundi, M., Akoum, A., Lapointe, R., Darveau, A. and Mourad, W. (2007) Requirement of oxidation-dependent CD40 homodimers for CD154/CD40 bidirectional signaling. J. Biol. Chem. 282, 19473-19480.
19. Deng, G. M., Zheng, L., Chan, F. K., and Lenardo, M. (2005) Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat. Med. 11, 1066-1072.
20. Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K., Johnson, M., Lynch, D., Tsien, R. Y., and Lenardo, M. J. (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354-2357.
21. Pound, J. D., Challa, A., Holder, M. J., Armitage, R. J., Dower, S. K., Fanslow, W. C., Kikutani, H., Paulie, S., Gregory, C. D., and Gordon, J. (1999) Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells. Int. Immunol. 11, 11-20.
22. Siepmann, K., Skok, J., van Essen, D., Harnett, M., and Gray, D. (2001) Rewiring of CD40 is necessary for delivery of rescue signals to B cells in germinal centres and subsequent entry into the memory pool. Immunology 102, 263-272.
23. Parker, D. C., Greiner, D. L., Phillips, N. E., Appel, M. C., Steele, A. W., Durie, F. H., Noelle, R. J., Mordes, J. P., and Rossini, A. A. (1995) Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92, 9560-9564.
24. Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, H. O., and Sarvetnick, N. (1997) CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159, 4620-4627.
25. Bishop, G. A., Moore, C. R., Xie, P., Stunz, L. L., and Kraus, Z. J. (2007) TRAF proteins in CD40 signaling. Adv. Exp. Med. Biol. 597, 131-151.
26. Dallman, C., Johnson, P. W., and Packham, G. (2003) Differential regulation of cell survival by CD40. Apoptosis 8, 45-53.
27. Hristov, K. K., Knox, K. A., and Mitev, V. I. (2005) Regulation of tyrosine phosphorylation during the CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis. Int. J. Mol. Med. 16, 937-941.
28. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., and Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
29. Grewal, I. S. and Flavell, R. A. (1996) A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol. Today 17, 410-414.
30. Maruo, S., Oh-hora, M., Ahn, H. J., Ono, S., Wysocka, M., Kaneko, Y., Yagita, H., Okumura, K., Kikutani, H., Kishimoto, T., Kobayashi, M., Hamaoka, T., Trinchieri, G., and Fujiwara, H. (1997) B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions. J. Immunol. 158, 120-126.
31. Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., and Delespesse, G. (1995) Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25, 1125-1128
32. Baker, R. L., Wagner, D. H., Jr., and Haskins, K. (2008) CD40 on NOD CD4 T cells contributes to their activation and pathogenicity. J. Autoimmun. 31, 385-392.
33. Laman, J. D., De Boer, M., and Hart, B. A. (1998) CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis. Dev. Immunol. 6, 215-222.
34. Lutgens, E., Lievens, D., Beckers, L., Donners, M., and Daemen, M. (2007) CD40 and its ligand in atherosclerosis. Trends Cardiovasc. Med. 17, 118-123.
35. Basok, A., Shnaider, A., Man, L., Chaimovitz, C., and Douvdevani, A. (2001) CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J. Am. Soc. Nephrol. 12, 695-702.
36. Thienel, U., Loike, J., and Yellin, M. J. (1999) CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets. Cell Immunol. 198, 87-95.
37. Chakrabarti, S., Blair, P., and Freedman, J. E. (2007) CD40-40L signaling in vascular inflammation. J. Biol. Chem. 282, 18307-18317.
38. Kotowicz, K., Dixon, G. L., Klein, N. J., Peters, M. J., and Callard, R. E. (2000) Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology 100, 441-448.
39. Schonbeck, U., Mach, F., Sukhova, G. K., Atkinson, E., Levesque, E., Herman, M., Graber, P., Basset, P., and Libby, P. (1999) Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J. Exp. Med. 189, 843-853.
40. Tedgui, A. and Mallat, Z. (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86, 515-581.
41. Schonbeck, U. and Libby, P. (2001) CD40 signaling and plaque instability. Circ. Res. 89, 1092-1103.
42. Mach, F., Schonbeck, U., Fabunmi, R. P., Murphy, C., Atkinson, E., Bonnefoy, J. Y., Graber, P., and Libby, P. (1999) T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40Ldependent mechanism: implications for tubule formation. Am. J. Pathol. 154, 229-238.
43. Smola-Hess, S., Schnitzler, R., Hadaschik, D., Smola, H., Mauch, C., Krieg, T., and Pfister, H. (2001) CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation. Exp. Cell Res. 267, 205-215.
44. Mosheimer, B. A., Kaneider, N. C., Feistritzer, C., Djanani, A., Sturn, D. H., Patsch, J. R., and Wiedermann, C. J. (2005) CD40-ligand-dependent induction of COX-2 gene expression in endothelial cells by activated platelets: inhibitory effects of atorvastatin. Blood Coagul. Fibrinolysis 16, 105-110.
45. Miller, D. L., Yaron, R., and Yellin, M. J. (1998) CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J. Leukoc. Biol. 63, 373-379.
46. Russo, S., Bussolati, B., Deambrosis, I., Mariano, F., and Camussi, G. (2003) Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction. J. Immunol. 171, 5489-5497.
47. Inoue, Y., Otsuka, T., Niiro, H., Nagano, S., Arinobu, Y., Ogami, E., Akahoshi, M., Miyake, K., Ninomiya, I., Shimizu, S., Nakashima, H., and Harada, M. (2004) Novel regulatory mechanisms of CD40-induced prostanoid synthesis by IL-4 and IL-10 in human monocytes. J. Immunol. 172, 2147-2154.
48. Melter, M., Reinders, M. E., Sho, M., Pal, S., Geehan, C., Denton, M. D., Mukhopadhyay, D., and Briscoe, D. M. (2000) Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96, 3801-3808.
49. Lapchak, P. H., Melter, M., Pal, S., Flaxenburg, J. A., Geehan, C., Frank, M. H., Mukhopadhyay, D., and Briscoe, D. M. (2004) CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island. Am. J. Physiol. Renal Physiol. 287, F512-520.
50. Eliopoulos, A. G., Stack, M., Dawson, C. W., Kaye, K. M., Hodgkin, L., Sihota, S., Rowe, M., and Young, L. S. (1997) Epstein-Barr virusencoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14, 2899-2916.
51. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., and Aruffo, A. (1995) Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182, 33-40.
52. Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., and Pober, J. S. (1995) CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92, 4342-4346.
53. Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D., and Chess, L. (1995) Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182, 1857-1864.
54. Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S., and Yamamoto, T. (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14-24.
55. Bishop, G. A., Hostager, B. S., and Brown, K. D. (2002) Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes. J. Leukoc. Biol. 72, 19-23.
56. Wajant, H., Henkler, F., and Scheurich, P. (2001) The TNF-receptorassociated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal. 13, 389-400.
57. Berberich, I., Shu, G., Siebelt, F., Woodgett, J. R., Kyriakis, J. M., and Clark, E. A. (1996) Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 15, 92-101.
58. Craxton, A., Shu, G., Graves, J. D., Saklatvala, J., Krebs, E. G., and Clark, E. A. (1998) p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161, 3225-3236.
59. Grammer, A. C., Swantek, J. L., McFarland, R. D., Miura, Y., Geppert, T., and Lipsky, P. E. (1998) TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J. Immunol. 161, 1183-1193.
60. Purkerson, J. M. and Parker, D. C. (1998) Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. J. Immunol. 160, 2121-2129.
61. Lee, N. K. and Lee, S. Y. (2002) Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs). J. Biochem. Mol. Biol. 35, 61-66.
62. Beinke, S. and Ley, S. C. (2004) Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382, 393-409.
63. Aljada, A., Friedman, J., Ghanim, H., Mohanty, P., Hofmeyer, D., Chaudhuri, A., and Dandona, P. (2006) Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 55, 1177-1185.
64. Bonizzi, G. and Karin, M. (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
65. Hayden, M. S. and Ghosh, S. (2004) Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.
66. Hanissian, S. H. and Geha, R. S. (1997) Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6, 379-387.
67. Jabara, H. H., Buckley, R. H., Roberts, J. L., Lefranc, G., Loiselet, J., Khalil, G., and Geha, R. S. (1998) Role of JAK3 in CD40-mediated signaling. Blood 92, 2435-2440.
68. Karras, J. G., Wang, Z., Huo, L., Frank, D. A., and Rothstein, T. L. (1997) Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J. Immunol. 159, 4350-4355.
69. Saemann, M. D., Kelemen, P., Zeyda, M., Bohmig, G., Staffler, G., and Zlabinger, G. J. (2002) CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibited. Transplant Proc. 34, 1407-1408.
70. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., and Soreq, H. (2005) Function of alternative splicing. Gene 344, 1-20.
71. Tone, M., Tone, Y., Fairchild, P. J., Wykes, M., and Waldmann, H. (2001) Regulation of CD40 function by its isoforms generated through alternative splicing. Proc. Natl. Acad. Sci. USA 98, 1751-1756.
72. Chatzigeorgiou, A., Lembessis, P., Mylona-Karagianni, C., Tsouvalas, E., Diamanti-Kandarakis, E., and Kamper, E. F. (2009), CD40 expression and its association with low-grade inflammation in a Greek population of type 1 diabetic juveniles: evidence for differences in CD40 mRNA isoforms expressed by peripheral blood mononuclear cells. Exp. Clin. End. Diab. 2009, Oct 15 (epub ahead of print).
73. Contin, C., Pitard, V., Itai, T., Nagata, S., Moreau, J. F., and Dechanet- Merville, J. (2003) Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. J. Biol. Chem. 278, 32801-32809.
74. Garton, K. J., Gough, P. J., and Raines, E. W. (2006) Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J. Leukoc. Biol. 79, 1105-1116.
75. Holler, N., Kataoka, T., Bodmer, J. L., Romero, P., Romero, J., Deperthes, D., Engel, J., Tschopp, J., and Schneider, P. (2000) Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. J. Immunol. Methods 237, 159-173.
76. Contin, C., Pitard, V., Delmas, Y., Pelletier, N., Defrance, T., Moreau, J. F., Merville, P., and Dechanet-Merville, J. (2003) Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients. Immunology 110, 131-140.
77. van Kooten, C., Gaillard, C., Galizzi, J. P., Hermann, P., Fossiez, F., Banchereau, J., and Blanchard, D. (1994) B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24, 787-792.
78. Sharma, M. D., Leite de Moraes, M., Zavala, F., Pontoux, C., and Papiernik, M. (1998) Induction and inhibition of CD40-CD40 ligand interactions: a new strategy underlying host-virus relationships. J. Immunol. 161, 5357-5365.
79. Eshel, D., Toporik, A., Efrati, T., Nakav, S., Chen, A., and Douvdevani, A. (2008) Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing. Mol. Immunol. 46, 250-257.
80. Chai, H., Yan, S., Wang, H., Zhang, R., Lin, P. H., Yao, Q., and Chen, C. (2006) CD40 ligand increases expression of its receptor CD40 in human coronary artery endothelial cells. Surgery 140, 236-242. (Pubitemid 44176065)
81. Qin, H., Wilson, C. A., Lee, S. J., Zhao, X., and Benveniste, E. N. (2005) LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 106, 3114-3122.
82. Nguyen, V. T. and Benveniste, E. N. (2000) Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J. Biol. Chem. 275, 23674-23684.
83. Nguyen, V. T. and Benveniste, E. N. (2002) Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma -induced CD40 expression in microglia/macrophages. J. Biol. Chem. 277, 13796-13803.
84. Benveniste, E. N., Nguyen, V. T., and Wesemann, D. R. (2004) Molecular regulation of CD40 gene expression in macrophages and microglia. Brain Behav. Immun. 18, 7-12.
85. Tone, M., Tone, Y., Babik, J. M., Lin, C. Y., and Waldmann, H. (2002) The role of Sp1 and NF-kappa B in regulating CD40 gene expression. J. Biol. Chem. 277, 8890-8897.
86. Qin, H., Wilson, C. A., Lee, S. J., and Benveniste, E. N. (2006) IFNbeta-induced SOCS-1 negatively regulates CD40 gene expression in macrophages and microglia. FASEB J. 20, 985-987.
87. Wesemann, D. R., Dong, Y., O'Keefe, G. M., Nguyen, V. T., and Benveniste, E. N. (2002) Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages. J. Immunol. 169, 2354-2360.
88. Lutgens, E. and Daemen, M. J. (2002) CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc. Med. 12, 27-32.
89. Laman, J. D., de Smet, B. J., Schoneveld, A., and van Meurs, M. (1997) CD40-CD40L interactions in atherosclerosis. Immunol. Today 18, 272-277.
90. Dullforce, P., Sutton, D. C., and Heath, A. W. (1998) Enhancement of T cell-independent immune responses in vivo by CD40 antibodies. Nat. Med. 4, 88-91.
91. Shiraki, K., Sugimoto, K., Okano, H., Wagayama, H., Fujikawa, K., Yamanaka, T., Ito, T., Ohmori, S., Sakai, T., Takase, K., and Nakano, T. (2006) CD40 expression in HCV-associated chronic liver diseases. Int. J. Mol. Med. 18, 559-563.
92. Toubi, E. and Shoenfeld, Y. (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37, 457-464.
93. Chiarelli, F., Giannini, C., Verrotti, A., Mezzetti, A., and Mohn, A. (2008) Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Metab. Res. Rev. 24, 570-576.
94. Poggi, M., Jager, J., Paulmyer-Lacroix, O., Peiretti, F., Gremeaux, T., Verdier, M., Grino, M., Stepanian, A., Msika, S., Burcelin, R., de Prost, D., Tanti, J. F., and Alessi, M. C. (2009) The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 52, 1152-1163.
95. Rizvi, M., Pathak, D., Freedman, J. E., and Chakrabarti, S. (2008) CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol. Med. 14, 530-538.
96. Chen, C., Chai, H., Wang, X., Jiang, J., Jamaluddin, M. S., Liao, D., Zhang, Y., Wang, H., Bharadwaj, U., Zhang, S., Li, M., Lin, P., and Yao, Q. (2008) Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood 112, 3205-3216.
97. Schwabe, R. F., Engelmann, H., Hess, S., and Fricke, H. (1999) Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients. Clin. Exp. Immunol. 117, 153-158.
98. Battaglia, E., Biancone, L., Resegotti, A., Emanuelli, G., Fronda, G. R., and Camussi, G. (1999) Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. Am. J. Gastroenterol. 94, 3279-3284.
99. Contin, C., Couzi, L., Moreau, J. F., Dechanet-Merville, J., and Merville, P. (2004) Immune dysfuntion of uremic patients: potential role for the soluble form of CD40. Nephrologie 25, 119-126.
100. Hock, B. D., McKenzie, J. L., Patton, N. W., Drayson, M., Taylor, K., Wakeman, C., Kantarjian, H., Giles, F., and Albitar, M. (2006) Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies. Cancer 106, 2148-2157.
101. Buchhave, P., Janciauskiene, S., Zetterberg, H., Blennow, K., Minthon, L., and Hansson, O. (2009) Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease. Neurosci. Lett. 450, 56-59.
102. Ait-ghezala, G., Abdullah, L., Volmar, C. H., Paris, D., Luis, C. A., Quadros, A., Mouzon, B., Mullan, M. A., Keegan, A. P., Parrish, J., Crawford, F. C., Mathura, V. S., and Mullan, M. J. (2008) Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease. Cytokine 44, 283-287.
103. Mocali, A., Cedrola, S., Della Malva, N., Bontempelli, M., Mitidieri, V. A., Bavazzano, A., Comolli, R., Paoletti, F., and La Porta, C. A. (2004) Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. Exp. Gerontol. 39, 1555-1561.
104. Luomala, M., Paiva, H., Laaksonen, R., Thelen, K., Lutjohann, D., Peltonen, N., and Lehtimaki, T. (2006) Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia. Scand. Cardiovasc. J. 40, 280-284.
105. Masunaga, T., Yamashita, K., Sakihama, H., Hashimoto, T., Hua, N., Imai, A., Inobe, M., Miyazaki, T., Todo, S., and Uede, T. (2005) Dimeric but not monomeric soluble CD40 prolongs allograft survival and generates regulatory T cells that inhibit CTL function. Transplantation 80, 1614-1622.
106. Komura, K., Fujimoto, M., Matsushita, T., Yanaba, K., Kodera, M., Kawasuji, A., Hasegawa, M., Takehara, K., and Sato, S. (2007) Increased serum soluble CD40 levels in patients with systemic sclerosis. J. Rheumatol. 34, 353-358.
107. Schmilovitz-Weiss, H., Belinki, A., Pappo, O., Sulkes, J., Melzer, E., Kaganovski, E., Kfir, B., Tur-Kaspa, R., Klein, T., and Ben-Ari, Z. (2004) Role of circulating soluble CD40 as an apoptotic marker in liver disease. Apoptosis 9, 205-210.
108. Shen, H. H., Sun, H. Y., Zhao, J. M., Hou, J., Bai, B. K., Hu, Y., Kong, W., and Mao, P. Y. (2008) Level and clinical significance of soluble CD40 in patients with chronic hepatitis B. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 22, 373-375.
109. Tsuzuki, M., Morishima, I., Yoshida, T., Hayashi, Y., Miura, M., Hirai, T., Asai, T., Numaguchi, Y., Sone, T., Matsui, H., Okumura, K., and Murohara, T. (2005) Inverse correlation between soluble CD40 ligand and soluble CD40 is absent in patients with unstable angina. Heart Vessels 20, 245-250.
110. Jinchuan, Y., Zonggui, W., Jinming, C., Li, L., and Xiantao, K. (2004) Upregulation of CD40--CD40 ligand system in patients with diabetes mellitus. Clin. Chim. Acta 339, 85-90.
111. Mysliwiec, J., Oklota, M., Nikolajuk, A., Waligorski, D., and Gorska, M. (2007) Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response. Immunol. Invest. 36, 247-257.
112. Salmaso, C., Olive, D., Pesce, G., and Bagnasco, M. (2002) Costimulatory molecules and autoimmune thyroid diseases. Autoimmunity 35, 159-167.
113. Mysliwiec, J., Waligorski, D., Nikolajuk, A., and Gorska, M. (2007) Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy. Adv. Med. Sci. 52, 104-108.
114. Town, T., Tan, J., and Mullan, M. (2001) CD40 signaling and Alzheimer's disease pathogenesis. Neurochem. Int. 39, 371-380.
115. MacDonald, K. P., Nishioka, Y., Lipsky, P. E., and Thomas, R. (1997) Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J. Clin. Invest. 100, 2404-2414.
116. Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledbetter, J. A., Boersma, W. J., and Claassen, E. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93, 2499-2504.
117. Buchner, K., Henn, V., Grafe, M., de Boer, O. J., Becker, A. E., and Kroczek, R. A. (2003) CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis. J. Pathol. 201, 288-295.
118. Santilli, F., Basili, S., Ferroni, P., and Davi, G. (2007) CD40/CD40L system and vascular disease. Intern. Emerg. Med. 2, 256-268.
119. Phipps, R. P. (2000) Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc. Natl. Acad. Sci. USA 97, 6930-6932.
120. Chakrabarti, S., Varghese, S., Vitseva, O., Tanriverdi, K., and Freedman, J. E. (2005) CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler. Thromb. Vasc. Biol. 25, 2428-2434.
121. Phipps, R. P., Koumas, L., Leung, E., Reddy, S. Y., Blieden, T., and Kaufman, J. (2001) The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curr. Opin. Investig. Drugs. 2, 773-777.
122. Davidson, A., Wang, X., Mihara, M., Ramanujam, M., Huang, W., Schiffer, L., and Sinha, J. (2003) Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE). Ann. NY Acad. Sci. 987, 188-198. (Pubitemid 36584022)
123. Karp, C. L., van Boxel-Dezaire, A. H., Byrnes, A. A., and Nagelkerken, L. (2001) Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10? Curr. Opin. Neurol. 14, 361-368.
124. Laman, J. D., t Hart, B. A., Brok, H., Meurs, M., Schellekens, M. M., Kasran, A., Boon, L., Bauer, J., Boer, M., and Ceuppens, J. (2002) Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12). Eur. J. Immunol. 32, 2218-2228.
125. t Hart, B. A., Brok, H. P., Amor, S., and Bontrop, R. E. (2001) The major histocompatibility complex influences the ethiopathogenesis of MSlike disease in primates at multiple levels. Hum. Immunol. 62, 1371-1381.
126. Schonbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., and Libby, P. (2000) Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 97, 7458-7463.
127. Costello, R. T., Gastaut, J. A., and Olive, D. (1999) What is the real role of CD40 in cancer immunotherapy? Immunol. Today 20, 488-493.
128. French, R. R., Chan, H. T., Tutt, A. L., and Glennie, M. J. (1999) CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat. Med. 5, 548-553.
129. van Mierlo, G. J., den Boer, A. T., Medema, J. P., van der Voort, E. I., Fransen, M. F., Offringa, R., Melief, C. J., and Toes, R. E. (2002) CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proc. Natl. Acad. Sci. USA 99, 5561-5566.
130. Vonderheide, R. H. (2007) Prospect of targeting the CD40 pathway for cancer therapy. Clin. Cancer Res. 13, 1083-1088.
131. Larsen, C. P., Alexander, D. Z., Hollenbaugh, D., Elwood, E. T., Ritchie, S. C., Aruffo, A., Hendrix, R., and Pearson, T. C. (1996) CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61, 4-9.
132. Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J., and Pearson, T. C. (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438.
133. Rolph, M. S. and Kaufmann, S. H. (2001) CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes. J. Immunol. 166, 5115-5121.
134. Pluvinet, R., Petriz, J., Torras, J., Herrero-Fresneda, I., Cruzado, J. M., Grinyo, J. M., and Aran, J. M. (2004) RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells. Blood 104, 3642-3646.
135. Siwkowski, A. M., Malik, L., Esau, C. C., Maier, M. A., Wancewicz, E. V., Albertshofer, K., Monia, B. P., Bennett, C. F., and Eldrup, A. B. (2004) Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucleic Acids Res. 32, 2695-2706